Medicinal use of Cannabis

On September 1, 2022, Executive Decree No. 121 was issued, with the purpose of creating the regulatory framework that allows the supervised and controlled use and access of cannabis and its derivatives, for therapeutic, medical, veterinary, scientific, and research purposes throughout the Republic of Panama, and at the same time prohibits the sale of medicinal cannabis door to door or by internet.

Any product derived from cannabis for the purposes at hand will be subject to a system of surveillance and supervision by the Ministry of Health, which is the competent authority to establish the requirements, receive applications for acquisition licenses, store, transport, dispense and/or market, consume and export cannabis and its derivatives for medicinal purposes.

By the same token, on September 1, 2022, Executive Decree No. 85 was issued, creating the National Directorate for the Monitoring of Activities Related to Medicinal Cannabis.

By: Arielka Zamora